Blood and Marrow Transplant Clinical Trials Network

Blood and Marrow Transplant Clinical Trials Network
Name	Blood and Marrow Transplant Clinical Trials Network
Formation	2001
Type	Clinical trials network
Headquarters	United States
Parent organization	National Institutes of Health

Blood and Marrow Transplant Clinical Trials Network The Blood and Marrow Transplant Clinical Trials Network is a cooperative clinical trials consortium focused on hematopoietic cell transplantation and cellular therapy. It designs and conducts multicenter studies that involve transplantation, immunology, oncology, and infectious disease researchers from leading institutions. Members include academic centers, hospitals, and government agencies working with professional societies, patient advocacy groups, and international collaborators.

Overview

The Network coordinates multicenter trials across major centers such as Dana–Farber Cancer Institute, Fred Hutchinson Cancer Center, MD Anderson Cancer Center, Mayo Clinic, and Johns Hopkins Hospital, engaging investigators affiliated with National Institutes of Health, National Cancer Institute, American Society of Hematology, European Society for Blood and Marrow Transplantation, and other entities. It integrates expertise from principal investigators with backgrounds linked to institutions like Stanford University School of Medicine, Harvard Medical School, University of Pennsylvania School of Medicine, University of California, San Francisco, and Columbia University Irving Medical Center to address clinical questions relevant to patients treated at centers such as Cleveland Clinic and Hospital of the University of Pennsylvania. The Network’s activities intersect with regulatory and advisory organizations including Food and Drug Administration, Centers for Disease Control and Prevention, World Health Organization, and professional groups like American Society of Clinical Oncology.

History and Organization

Established through initiatives associated with the National Heart, Lung, and Blood Institute and the National Cancer Institute, the Network grew from earlier cooperative groups and transplant consortia that traced roots to programs at Seattle Cancer Care Alliance and trials led by investigators from University of Minnesota Medical School and Fred Hutchinson Cancer Research Center. Organizational governance involves steering committees, protocol committees, and data monitoring boards with leadership drawn from institutions such as Brigham and Women's Hospital, Yale School of Medicine, University of Michigan Health System, and Children's Hospital of Philadelphia. The Network has structured trial operations with clinical coordinating centers modeled after cooperative groups like the Cancer and Leukemia Group B and engages statistical centers akin to those at Mayo Clinic Cancer Center and Ohio State University Comprehensive Cancer Center.

Research Programs and Clinical Trials

Research spans graft-versus-host disease, donor selection, conditioning regimens, cellular therapies, and infectious complications evaluated in trials at centers including Memorial Sloan Kettering Cancer Center, Rockefeller University, University of California, Los Angeles, and Duke University Hospital. Notable trial topics overlap with gene therapy programs at Children's Hospital of Philadelphia and immunotherapy initiatives at City of Hope, exploring endpoints similar to studies conducted by National Marrow Donor Program and registries managed by Center for International Blood and Marrow Transplant Research. Trials have evaluated reduced-intensity conditioning developed by teams associated with Fred Hutchinson Cancer Center and donor lymphocyte infusion strategies investigated by investigators from University of Florida Health and Vanderbilt University Medical Center. Pediatric transplant protocols connect with St. Jude Children's Research Hospital and Boston Children's Hospital, while adult trials involve centers such as Mount Sinai Health System and Northwestern Memorial Hospital.

Collaborations and Partnerships

The Network partners with academic institutions, professional societies, patient groups, and international transplant organizations, collaborating with European Society for Blood and Marrow Transplantation, Japan Society for Hematopoietic Cell Transplantation, Canadian Blood Services, and registries like Be The Match. It has aligned research priorities with funders and policy stakeholders including National Institutes of Health, Bill & Melinda Gates Foundation, and philanthropic entities linked to hospitals such as Memorial Sloan Kettering Cancer Center and St. Jude Children's Research Hospital. Cross-disciplinary collaboration involves immunologists from Rockefeller University, virologists connected to Centers for Disease Control and Prevention, and biostatisticians affiliated with Johns Hopkins Bloomberg School of Public Health.

Funding and Governance

Primary funding streams originate from divisions within National Institutes of Health and cooperative agreements with the National Cancer Institute and National Heart, Lung, and Blood Institute, supplemented by grants from foundations associated with Leukemia & Lymphoma Society and support from institutional partners like Mayo Clinic and Dana–Farber Cancer Institute. Governance is overseen by steering committees and data safety monitoring boards with ethical oversight linked to institutional review boards at sites such as Columbia University Irving Medical Center and University of Chicago Medical Center. Financial oversight and contracting follow practices similar to networks funded by Medical Research Council-style agencies and align with reporting expectations of agencies like Office of Management and Budget.

Impact and Outcomes

The Network’s trials have informed standards of care at transplant centers including Fred Hutchinson Cancer Center, MD Anderson Cancer Center, and Dana–Farber Cancer Institute, influencing guidelines promulgated by American Society of Hematology and American Society for Transplantation and Cellular Therapy. Outcomes research contributed to improvements in survival and reduced morbidity documented in registries like the Center for International Blood and Marrow Transplant Research and has supported advances in chimeric antigen receptor T‑cell therapy programs rooted at University of Pennsylvania, Memorial Sloan Kettering Cancer Center, and Fred Hutchinson Cancer Center. The Network’s work continues to shape donor selection, conditioning protocols, and management of complications across pediatric and adult transplantation practiced at centers such as St. Jude Children's Research Hospital, Children's Hospital of Philadelphia, and Johns Hopkins Hospital.

Category:Clinical trial networks